Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication Protocol Without Ranitidine for Taxane Regimen
TCTR20210322004Phase 3Completed
- Sponsor
- N/A
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 3, open-label trial in Nonhematologic neoplasms (2 arms), sponsored by N/A. Primary endpoint: Efficacy of premedication protocol without ranitidine. Started Mar 2021; status: completed.
02
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on TCTR20210322004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210322004.